Top Markets
#1 MarsCoin MarsCoin +28.79%
#2 Palladium Network Palladium Network +27.94%
#3 Siren Siren +24.91%
#4 Hive Hive +20.08%
#5 BankrCoin BankrCoin +19.78%
#6 Ankr Network Ankr Network +18.44%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#8 StonkBroker StonkBroker +14.75%
#9 Pons Pons +11.03%
#10 Status Status +9.74%
Coin of the day
MarsCoin MarsCoin
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
NovaBridge Biosciences NovaBridge Biosciences

NovaBridge Biosciences

NBP
Rankning i aktier #18279
NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering... NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several significant drug candidates: givastomig, a bispecific antibody currently in Phase 1b clinical trials for gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, another bispecific antibody, which is undergoing Phase 1 clinical evaluation for solid tumors. The company maintains a strategic licensing agreement with Ferring International Center SA, encompassing the research, development, manufacturing, import, use, and commercialization rights for FE301, an interleukin-6 inhibitor. Additionally, NovaBridge Biosciences has established collaborations with Bristol Myers Squibb for givastomig's advancement, ABL Bio, Inc. for both givastomig and ragistomig, and TJ Bio for uliledlimab. Founded in 2014 and headquartered in Rockville, Maryland, the entity was formerly named I-Mab, with its transition to NovaBridge Biosciences slated for October 2025.
Aktiekurs
$1.79
Senast synkroniserad: 2026-09-02
Marknadsvärde
$205.75M
Förändring (1 dag)
3.18%
Förändring (1 år)
-61.61%
Land
US
Handel NovaBridge Biosciences (NBP)

Kategori

Healthcare
Aktiekurshistorik för NovaBridge Biosciences (NBP)
Högsta slutkurs: $1.76 den 2026-09-01

Lägsta slutkurs: $13.69 den 2020-01-01
Aktiekurshistorik för NovaBridge Biosciences från 2020 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -24.42%
2025 320.81%
2024 -37.56%
2023 -57.87%
2022 -92.59%
2021 24.83%
2020 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 40.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 45.39%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 535.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.17 -8.86%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 6.76%
CH